# Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

> **NCT01229462** · NA · COMPLETED · sponsor: **Allergan** · enrollment: 238 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** brimonidine tartrate/timolol fixed combination ophthalmic solution
- **DRUG:** brimonidine tartrate ophthalmic solution
- **DRUG:** timolol ophthalmic solution
- **OTHER:** fixed combination vehicle

## Key facts

- **NCT ID:** NCT01229462
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2012-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229462, "Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01229462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*